Elena Giardino Selected Research

somatostatin receptor 5

1/2021	Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells.
1/2019	Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena Giardino Research Topics

Disease

6	Pituitary Neoplasms (Pituitary Adenoma) 01/2021 - 01/2015
5	Neoplasms (Cancer) 01/2021 - 01/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021
1	Acromegaly 01/2020
1	Pituitary ACTH Hypersecretion 01/2019
1	Neurologic Manifestations (Neurological Manifestations) 01/2015

Drug/Important Bio-Agent (IBA)

4	FilaminsIBA 01/2021 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021 - 01/2015
2	Hormones (Hormone)IBA 01/2021 - 01/2015
2	pasireotideIBA 01/2021 - 01/2019
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 01/2019
2	somatostatin receptor 5IBA 01/2021 - 01/2019
2	ProlactinIBA 01/2021 - 01/2015
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2021 - 01/2021
2	somatostatin receptor 2IBA 01/2021 - 01/2020
2	Growth Hormone (Somatotropin)IBA 01/2020 - 01/2015
1	beta-Arrestin 2IBA 01/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2020
1	Cytostatic AgentsIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2015

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2015